
Morgan Stanley analyst Shane Brett downgraded semiconductor equipment specialist Lam Research (LRCX) from Equalweight to Underweight, lowering the price target to $92 from $94. This action, which prompted a 3% share decline, reflects concerns over the company's ability to sustain high growth beyond 2026, specifically citing challenges in China market share expansion and the long-term potential of its NAND memory business. The analyst's view suggests the stock is overvalued at its current price given these future headwinds, despite no fundamental issues with management or core operations.
A recent downgrade of Lam Research (LRCX) by a Morgan Stanley analyst to 'underweight' from 'equalweight' has introduced significant bearish sentiment, contributing to a 3% share price decline that outpaced the broader market's 0.7% dip. The analyst's thesis is not based on current operational failures but on a forward-looking view that the company's recent high growth rates are unsustainable into 2026. This perspective is rooted in two specific pressures: anticipated challenges in expanding market share in China and weakening growth potential from its NAND memory business, whose end markets are seen as lacking the capacity to drive further fundamental improvements. The analyst's price target was also trimmed to $92 from $94 per share. Importantly, the negative call is directed at the company's valuation in the context of its customer base and end-market prospects, rather than a critique of Lam's management or internal business execution.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment